)
)
60 Degrees Pharmaceuticals Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from 60 Degrees Pharmaceuticals Inc
Access all reports
60 Degrees Pharmaceuticals Inc. is a pharmaceutical company focused on developing and commercializing treatments for infectious diseases, particularly those affecting travelers and people in tropical and subtropical regions. The company’s primary focus is on therapeutics for diseases such as malaria and dengue fever, aiming to address unmet needs in global health. 60 Degrees Pharmaceuticals collaborates with various research organizations and government agencies to advance its product pipeline and expand access to its treatments in underserved regions. The company is headquartered in Washington, D.C., and its shares are listed on the NASDAQ.
Latest articles
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
)
Mips: The Gore-Tex of Brain Protection
How Mips turned a critical safety flaw into a global success, redefining helmet protection with its technology and ingredient brand business model.
24 Jan 2025
Ticker symbol
SCTP
Country
🇺🇸 United States